肝癌是我国最常见的恶性肿瘤,无论是原发性肝癌亦或是继发性肝癌,除部分早期的患者可进行手术治疗外,其放疗和化疗效果都很差。近年来,随着分子遗传学技术的迅猛发展和对肝癌发病机制认识的不断深入,肝癌的基因治疗已越来越受到人们的重视,并日渐成为一有前景的治疗选择。 Liver cancer is the most common malignant tumor in our country. No matter it is primary liver cancer or secondary liver cancer, except for some early patients who can undergo surgical treatment, their radiotherapy and chemotherapy effects are very poor. In recent years, with the rapid development of molecular genetics technology and the deepening understanding of the pathogenesis of liver cancer, gene therapy of liver cancer has drawn more and more attention and is becoming a promising treatment option gradually.